Lithium Toxicity After a Thiazide Is Added: Level, Dialysis, and What Comes After
A 61-year-old woman with bipolar I disorder, stable on lithium 900 mg nightly for 8 years, is brought in by her daughter with 3 days of vomiting, coarse tremor, unsteady gait, and confusion. Two weeks ago hydrochlorothiazide was added for hypertension. Lithium level is 2.7 mEq/L. She is afebrile; heart rate 96/min, BP 98/62 mmHg, respirations 20/min. She is oriented to person only, with marked intention tremor and ataxia. Creatinine 1.8 mg/dL (baseline 0.9), sodium 133 mEq/L, potassium 4.4 mEq/L, urine output 25 mL/h. Head CT is unremarkable. She is not suicidal, and there are no focal deficits.
1. Explain why this presentation is more dangerous than the same level would be in an acute overdose, and identify the mechanism by which the new medication precipitated it.
Read the worked answer
Chronic versus acute toxicity is the key distinction, and the number alone does not capture it.
In an acute overdose the ingested lithium is still largely in the extracellular space - the patient may have a level of 4–5 mEq/L with relatively mild symptoms, and the level keeps rising as absorption completes. In chronic toxicity, lithium has equilibrated into tissue, including brain, over days to weeks. The total body burden is high and the brain-to-serum ratio is greater, so neurologic symptoms occur at much lower levels - and a level of 2.7 with confusion and ataxia is a genuine emergency, not a borderline result. In chronic toxicity, the level correlates poorly with severity; treat the patient, not the number.
Mechanism: thiazides block distal tubular sodium reabsorption, causing mild volume depletion and increased proximal sodium reabsorption - and lithium is handled like sodium, so its renal clearance falls (by roughly 25%). That effect appears within days to a couple of weeks of starting the drug, and her vomiting has compounded the volume depletion (urine output 25 mL/h, creatinine doubled). Other precipitants in the same family: NSAIDs, ACE inhibitors/ARBs, dehydration, and low-salt diets.
Rule out mimics: no rigidity, clonus, or hyperreflexia (argues against serotonin syndrome or NMS), she is afebrile, and head CT is negative. The history does the work - a new thiazide 2 weeks ago is the answer.
2. Write the acute management plan, including the specific indications you would use to call nephrology for hemodialysis and the pitfall that follows a successful session.
Read the worked answer
Initial management:
- Stop lithium and hydrochlorothiazide. Substitute amlodipine (or another thiazide-free agent) for blood pressure.
- Restore volume with 0.9% saline IV - she is volume depleted, and saline both improves renal perfusion and promotes lithium excretion. Monitor urine output and creatinine.
- Avoid NSAIDs, ACE inhibitors, and ARBs during the episode.
- Supportive care: seizure precautions, aspiration precautions, frequent neuro checks, continuous cardiac monitoring (sinoatrial block, bradyarrhythmias, QT prolongation).
- Serial lithium levels every 2–4 h initially.
- Do not rely on whole-bowel irrigation or activated charcoal - charcoal does not bind lithium.
Call nephrology for hemodialysis when any of the following is present:
- Severe neurologic findings - altered consciousness, seizures, coma (present here)
- Lithium level >2.5 mEq/L with renal impairment (present here) or >4 mEq/L at any time
- Life-threatening arrhythmia or hemodynamic instability
- Failure to improve with supportive care
She meets at least two criteria, so dialysis should be arranged urgently rather than watched overnight.
The pitfall: rebound. Lithium redistributes from tissue back into serum after dialysis, so the level can climb again within hours. Use a lithium-free dialysate, run a full 4-hour session, recheck the level ~6 h after the session, and repeat dialysis if it rebounds above ~1 mEq/L with persistent symptoms. Continuous renal replacement therapy is an option if she is too unstable for intermittent dialysis.
3. Assume she recovers renal function. Address three things: whether to resume lithium, how you would monitor it, and how you handle her current decision-making capacity.
Read the worked answer
1. Resuming lithium - usually yes, carefully. She has 8 years of stability on lithium, and lithium has the strongest evidence of any mood stabilizer for reducing suicide risk and preventing both poles. Abandoning an effective drug because of an iatrogenic interaction can cost her mood stability. Reasonable plan: recover renal function first (creatinine back near baseline), then restart at a lower dose (e.g., 600 mg nightly), with a thiazide-free antihypertensive (amlodipine) and explicit avoidance of NSAIDs.
If lithium is not feasible, consider divalproex (with LFT/platelet monitoring) or lamotrigine (slow titration, rash risk) - but this is a downgrade from a drug known to work for her.
2. Monitoring.
- Level 5–7 days after any dose change and after any new interacting drug; then every 3–6 months once stable
- Creatinine/eGFR every 3–6 months, TSH and calcium annually (hypothyroidism and hyperparathyroidism are chronic lithium effects)
- Target trough 0.6–0.8 mEq/L for maintenance
- Sick-day rules in writing: hold lithium during vomiting, diarrhea, fever, or poor intake; call before starting any new medication
3. Capacity. She is delirious from lithium toxicity and currently lacks decision-making capacity for anything beyond emergency stabilization. Proceed with dialysis and treatment under emergency doctrine, document the capacity assessment, and involve her daughter for collateral history and disposition planning. Capacity should be reassessed after she is euthymic and clear-headed - a delirious refusal is not the same as an informed one, and a psychiatric advance directive or outpatient discussion should follow once she recovers.